Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030. Pfizer Inc (NYSE: PFE) has closed a $43 billion deal to acquire biotechnology...
Tag: Seagen
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, Washington-bas...
Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech’s stock pops 20%
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to ...
Pfizer favored over Merck for Seagen acquisition: SVB analyst
Pfizer’s (PFE) interest in Seagen (SGEN) marks the second time in a year the cancer-focused biotech has been an acquisition target by a major pharmaceutical player in the cancer space. Seagen wa...
Seagen stock opened 13% up on Monday: find out why
Seagen Inc (NASDAQ: SGEN) opened more than 10% up this morning on reports that Pfizer Inc (NYSE: PFE) is interested in buying the cancer therapies company. Here’s what we know so far On Monday, anonym...
Affirm, Electronic Arts, Dell, Seagen and more
Electronic Arts (EA) signage is displayed on the back of a chair at the company’s campus in Burnaby, British Columbia, Canada. Ben Nelms | Bloomberg | Getty Images Electronic Arts (EA) signage i...
Merck Looks Attractive, With or Without Seagen
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
Merck in Advanced Talks to Buy Biotech Company Seagen
The regulatory concerns associated with the potential deal between Merck and Seagen may attract antitrust scrutiny from regulators. American multinational pharmaceutical company Merck & Co Inc (N...
Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck
Seagen (SGEN) – Get Seagen Inc. Report shares powered higher Thursday following a report from the Wall Street Journal that it’s in advanced takeover talks with drugmaker Merck & Co. ...
GameStop, Seagen, Virgin Galactic and more
Check out the companies making headlines before the bell: GameStop (GME) – GameStop rallied 7.8% in the premarket after the videogame retailer declared a 4-for-1 stock split. Trading on a split-adjust...
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion
Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...
Merck Pushes Forward With Potential Deal for Seagen
Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year. The Wall Stre...
CarMax, FedEx, Seagen and more
Check out the companies making headlines before the bell: CarMax (KMX) – The automobile retailer beat estimates by 7 cents with quarterly earnings of $1.56 per share, and revenue that also beat analys...
Seagen, Moderna, Utz, Kroger and more
The Kroger supermarket chain’s headquarters is shown in Cincinnati, Ohio. Lisa Baertlein | Reuters Check out the companies making headlines in midday trading Friday. Seagen — Shares of the biote...
Top Stocks To Buy This Week
Q.ai The equities market declined last week following the release of the Federal Reserve’s March meeting minutes. Amongst other indications, Fed officials are planning for several more interest rate h...